Groww Logo

Vivimed Labs Financial Statements

Quarterly
Yearly
ParticularsDec '20Mar '21Jun '21Sep '21Dec '21
Revenue277.9438.9965.2654.3856.52
Expenses316.3259.4759.0069.2068.26
EBITDA-38.38-20.486.26-14.82-11.74
EBIT-54.90-24.611.73-19.17-16.19
Profit Before Tax-50.17-27.90-2.34-23.30-23.68
Net Profit-49.55-27.46-2.34-23.30-23.68
Financial Ratios
Operating Profit Margin-13.81%-52.53%9.58%-27.25%-20.77%
Net Profit Margin-17.83%-70.43%-3.59%-42.85%-41.90%
Earning Per Share (Diluted)-5.98-3.31-0.28-2.81-2.86
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 2.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI